It is probably anecdotal, but Akzo had difficulty in conducting its planned webinar. On the other hand this fits with the potential internal challenges, which will have to be countered with via another programme, this time not purely focused on cost cutting.
Akzo’s Q2 was a mixed bag, beating our estimates by +14.6% (consensus: +4.5%) on the top line while the adjusted EBITDA fell short by -1.8% relative to our estimates (consensus: -5.2%). The EBIT miss was even greater (Alphavalue: -17.8%; co ....
20 Jul 2022
Are the 2023 targets still in reach?
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Are the 2023 targets still in reach?
It is probably anecdotal, but Akzo had difficulty in conducting its planned webinar. On the other hand this fits with the potential internal challenges, which will have to be countered with via another programme, this time not purely focused on cost cutting.
Akzo’s Q2 was a mixed bag, beating our estimates by +14.6% (consensus: +4.5%) on the top line while the adjusted EBITDA fell short by -1.8% relative to our estimates (consensus: -5.2%). The EBIT miss was even greater (Alphavalue: -17.8%; co ....